Hamostaseologie

Article	Citations
Veranstaltung des BDDH am 03.03.2022 im Rahmen der 66. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) in Leipzig	64
GTH 2025 ARTE: The Art in Science – Curiosity and Creativity	36
Medizinforschungsgesetz, Apothekenreform-Gesetz, Telemedizin Blutspende-Verordnung, Erweiterung der Dokumentationspflichten im Deutschen Hämophilieregister (DHR)	27
Übergewicht und Adipositas erhöht Risiko für venöse Thromboembolien	19
Current Topics from the Revised German S2k Guideline on Diagnosis and Treatment of Venous Thromboembolism	19
	18
Erratum: Aktueller Bericht der BDDH über die aktuellen gesundheitspolitischen Entwicklungen mit politischer Einordnung	18
Asundexian and milvexian: Pharmacodynamic insights from coagulation assays	17
ITAM upregulation in platelets after major surgery	15
Platelet activating histone/anti-histone immune complexes are associated with a new entity of thrombosis and thrombocytopenia syndrome	15
A novel assay to quantify extrinsic tenase complexes in body fluids	15
Tolerance Breakdown in Hemophilia A Mice is Orchestrated by Bacterial Infection Modulating Antigen-Specific B and T cell Responses	15
	15
Hemophilia care from pediatrics to adulthood – a model of joint interdisciplinary guided transition at a Hemophilia Comprehensive Care Center (HCCC)	14
Assessing the impact of a pulmonary embolism response team on patients presenting with intermediate risk acute pulmonary embolism. A prospective study (ongoing)	12
Long-term management of deep vein thrombosis based on medical history - A prospective cohort analysis	11
Gabapentin and pregabalin can be associated with clinically relevant bleeding due to disturbed platelet function – Two case reports	10
Splanchnic Vein Thrombosis: The State-of-the-Art on Anticoagulant Treatment	10
Elevated von Willebrand factor levels during anticoagulation predict early recurrence of venous thromboembolism	10
Checkpoint Inhibitors, CAR T Cells, and the Hemostatic System: What Do We Know So Far?	10
Platelets in Myocardial Ischemia/Reperfusion Injury	9
Subsegmental Pulmonary Embolism	8
Autoantibody-induced platelet Fc-gamma-RIIA-mediated procoagulant platelets are important drivers of immunothrombosis in antiphospholipid syndrome	7
Blutspende auch ohne Arztanwesenheit und aktueller Stand des Apothekenreform-Gesetzes (ApoRG)	7
Komplementdysregulation als Biomarker für Post Covid	7

A Vicious Circle of Clonal Haematopoiesis of Indeterminate Potential and Cardiovascular Disease	7
Management of Hemophilia C (Factor XI Deficiency) in Two Families: A Case Study at the University Hospital of Halle (Saale)	7
Die Gesellschaft für Thrombose- und Hämostaseforschung e.V. informiert	7
High Prevalence of Plasminogen Activator Inhibitor-1 4G/5G Polymorphism among Patients with Venous Thromboembolism in Kerala, India	7
Differential platelet activation and thrombo-inflammatory mechanisms in early onset and late onset preeclampsia	7
The Current Evidence of Pulmonary Embolism Response Teams and Their Role in Future	7
Immune Thrombocytopenia: Characteristics of the Population and Treatment Methods—One-Center Experience	7
Targeting antigen-specific B cells in immune mediated thrombotic thrombocytopenic purpura using modular CAR T cells	6
Results of an international survey (ISTH) on the management of therapeutic-intensity unfractionated heparin	6
Venous Thromboembolism in Women with Cancer with an Additional Focus on Breast and Gynecological Cancers	6
Increased transfusion requirement in children compared to adults undergoing cardiac surgery	6
Efficacy of Rivaroxaban in Children with Short Bowel Syndrome	6
Enhanced platelet turnover after acute myocardial infarction in thrombocytopenic mice and GPVI-deficient mice	6
Pregnancy complications in female haemophilia patients and carriers of haemophilia A and B- a nationwide survey	6
Management of Antithrombin Deficiency in Pregnancy	6
Thrombocytopenia Absent Radius (TAR)-Syndrome: From Current Genetics to Patient Self-Empowerment	6
Petition „Vergütung für medizinische Leistungen – Verbesserung der Rahmenbedingungen für die ambulante Versorgung“, ATMP-QS-Richtlinie Hämophilie und aktueller Stand zur Digitalisierung im Gesundheits	5
Erratum: A Novel Fibrinogen Mutation p.BβAla68Asp Causes an Inherited Dysfibrinogenemia	5
Reference Intervals in Coagulation Analysis	5
Correlation between Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio and Burden of Thrombus with Disease Severity in Patients with Pulmonary Thromboembolism	5
GTH News	5
Evidence in Haemophilia Assessment: The Haemophilia Joint Health Score	5
Runder Tisch zum deutschen Hämophilieregister (DHR), drohender Praxenkollaps, Stand und Zukunft der ambulanten hämostaseologischen Versorgung in Deutschland	5
Bleeding Disorder of Unknown Cause: A Diagnosis of Exclusion	5
Influence of coagulation proteases on cognitive function	4
Familial Protein S deficiency with severe venous thromboembolism (VTE)	4
Venous Thrombosis and SARS-CoV-2	4
The Impact of non-factor VIII therapy in haemophilia A on procoagulant platelets	4
Echtzeit-Bildgebung der durch Blutplättchen induzierten Blutgerinnselbildung und -auflösung zeigt unterschiedliche Auswirkungen von Antikoagulantien	4
Cardiac and Cerebral Arterial Complications of Lemierre Syndrome: Results from a Systematic Review and Individual Patient Data Meta-analysis	4
Hypofibrinolytic dysregulations can be detected of frozen plasma samples using viscoelastic testing	4
Platelets and COVID-19	4
Neuigkeiten zur Ablösung der geplanten Ablösung der In-Vitro-Diagnostika-Richtlinie durch die In-Vitro-Diagnostika-Verordnung (IVDR) 05/2022 und Plasmaversorgung in Deutschland/EU und Fortführung der	3
Role of Tissue Transglutaminase 2 in Fibrin Formation and Haemostasis	3
Diagnosis of Platelet Function Disorders: A Challenge for Laboratories	3
Bleeding Risk in Patients with Cancer	3
Haemostaseological pearls	3
Endothelial Mechanisms Modulate the Prothrombotic Phenotype of Factor V Leiden Carriers: Evidence from an Ex Vivo Model	3
Changes in Hemophilia Treatment in the Eastern Part of Germany between 2015 and 2021—Data from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)	3
Update des Versorgungsvertrages nach § 132 i SGBV	3
Veranstaltung des BDDH im Rahmen der 67. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung in Frankfurt	3
The Use of Large Animal Models in Trauma and Bleeding Studies	3
Development and evaluation of a novel machine learning algorithm for outpatient thrombophilia diagnosis, management, and venous thrombosis risk stratification	3
Treatment of Inherited Platelet Disorders: Current Status and Future Options	3
Acquired von Willebrand Syndrome in Children	3
Transfusion älterer Erythrozyten erhöht Mortalität und Thromboembolie-Risiko	3
GTH News	3
	3
Recognizing inherited platelet disorders on the peripheral blood smear by immunofluorescence microscopy: results of the first international workshop	3
Inhibition of MicroRNA-122-5p Relieves Myocardial Ischemia-Reperfusion Injury via SOCS1	3

A patient with Klippel-Trénaunay-Syndrom and cerebral venous sinus thrombosis	3
Communication in Healthcare: Global challenges in the 21st Century	3
Geringe α-Thrombin/GPIbα-Interaktion trägt möglicherweise zur Hyperreaktivität der Thrombozyten bei COVID-19-Patienten bei	3
	3
Gleiches Risiko für schwere kardiovaskuläre Ereignisse nach hämorrhagischem und ischämischem Schlaganfall	3
Experiences in Routine Genetic Analysis of Hereditary Hemorrhagic, Thrombotic, and Platelet Disorders	3
GTH News	2
Identification of novel cryptic epitopes uncovers a distinct and consistent open ADAMTS13 conformation in iTTP	2
Treatment of Atypical Clots	2
Cardio-Oncology: A New Discipline in Medicine and Its Relevance to Hematology	2
Residuale Venenokklusion nach längerer Antikoagulanzien-Therapie nicht mit erneuten venösen Thromboembolien assoziiert	2
Quantifying Residual Rivaroxaban Plasma Concentration after Antagonization with Andexanet Alfa: A Difficult Task in Routine Clinical Practice	2
In Japan 40% Blutungskomplikationen während ECMO-Therapie bei COVID-19	2
A Review of FXIa Inhibition as a Novel Target for Anticoagulation	2
Determination of thrombotic risk in patients with antiphospholipid syndrome using a modified thrombin generation assay	2
Recombinant factor VIII binding to platelets influences fibrin clot formation and stability	2
Stable Factor IX Expression and Sustained Reductions in Factor IX Use 8 Years After Gene Therapy With CSL220 (Formerly AMT-060) in Adults with Hemophilia B [ENCORE]	2
Marker der Akute-Phase-Reaktion könnten Blutungen bei Hämophilie detektieren	2
Platelet Dysregulation in the Pathobiology of COVID-19	2
Venous Thromboembolism Issues in Women	2
Investigating the impact of oligogenic variation on severity of bleeding in hypofibrinogenemia	2
The Great Return: Rebuilding and Advancing the Swiss Haemophilia Registry	2
Genetic Analysis of Hereditary Coagulation Factor V Deficiency in Two Chinese Families Caused by Compound Heterozygous Mutations	2
Recurrent Venous Thromboembolism in Patients on Anticoagulation: An Update Based on the Revised AWMF S2k Guideline	2
Use of Vonicog Alpha and Acquired von Willebrand Syndrome, a New Approach: A Case Report	2
Primary Prevention of Cancer-Associated Thrombosis: Current Perspectives	2
Integration of Extracorporeal Membrane Oxygenation into the Management of High-Risk Pulmonary Embolism: An Overview of Current Evidence	2
Advancing Treatment Options: Two Phase 3 Studies Investigating the Efficacy, Safety, and Pharmacokinetics of an Antithrombin Concentrate in Patients with Congenital and Acquired Antithrombin Deficienc	1
Fibrinogen Bonn (p. Arg510Cys) in the Aα-Chain Is Associated with High Risk of Venous Thrombosis	1
The Role of Platelet microRNAs in Cancer	1
Chronic Venous Disease: Pathophysiological Aspects, Risk Factors, and Diagnosis	1
Surface expression patterns in immature versus mature platelets of bleeding patients with abnormal light transmission aggregometry	1
Management of Vascular Thrombosis in Patients with Thrombocytopenia	1
GTH News	1
Emicizumab for the Treatment of Acquired Hemophilia A: Consensus Recommendations from the GTH-AHA Working Group	1
First Interim Analysis of Clinical Outcomes in Adults and Adolescents With Severe Hemophilia A Receiving Efanesoctocog Alfa Prophylaxis in XTEND-ed, a Phase 3 Long-term Extension Study	1
Intensive lifestyle intervention on thrombin generation in individuals at high risk for type 2 diabetes	1
Guidance-Based Appropriateness of Hemostasis Testing in the Acute Setting	1
Reform des Kapitels 32 (Laboratoriumsmedizin) im einheitlichen Bewertungsmaßstab (EBM)	1
Animal and Cellular Models in Thrombosis and Hemostasis	1
Intravital Imaging of Thrombosis Models in Mice	1
Managing immune thrombocytopenia (ITP) during pregnancy- Single centre 15 years experience at a tertiary care institute	1
Digenic Inheritance of PROC and SERPINC1 Mutations Contributes to Multiple Sites Venous Thrombosis	1
Successful Secondary Endovascular Intervention in Pediatric Patients with Venous Thromboembolic Events	1
vWF/GPIb mechano-dependent interactions require F-actin disassembly by the oxidoreductase MICAL1	1
Crosstalk between platelets and red blood cells promotes abdominal aortic aneurysm formation and progression	1
Thrombosis in Acute Promyelocytic Leukemia: The Current Understanding	1
Leichte Schlaganfälle: Thrombolyse und routinemäßige medi-zinische Versorgung im Vergleich	1
Progress in Hemostasis (Part 1): Improved Management of Inherited Platelet Disorders: Reality or Illusion?	1
Osteoporosis Remains Constant in Patients with Hemophilia—Long-Term Course in Consideration of Comorbidities	1
Feasibility of a VWF:Ag latex immunoassay on a fully automated coagulation analyzer	1
NBEAL2 related Gray Platelet Syndrome with a combined platelet granules secretion defect in flow cytometry	1
Treatment Burden during a Phase 3 Randomized, Crossover Study of Recombinant ADAMTS13 Prophylaxis and Standard of Care in Patients with Congenital Thrombotic Thrombocytopenic Purpura	1
Novel Perspectives on Thrombopoietin Receptor Agonists Applications	1
The Potential of HMB-001 as a Prophylactic Treatment of Glanzmann Thrombasthenia: Interim Analysis of the Phase 2 Study	1
Apixaban for thromboprophylaxis in paediatric cardiology patients – Real-world data from a single institution	1
Evaluating the prevalence and profile of antibodies against Polyethylene Glycol in hemophilia patients and healthy Individuals	1
Microvascular Skin Manifestations Caused by COVID-19	1
Glycoprotein-specific antibodies modulates platelet phenotypes in an epitope-dependent manner	1
	1
Influence of atmospheric conditions and air pollution on pulmonary embolism incidence and severity: findings from a retrospective cohort study	1
Laudatio auf Rüdiger E. Scharf	1
Fibrin exposition on the surface of the remaining part of arterial thrombus arrests the thrombus growth	1
Erhöhte Faktor-VIII-Aktivität – gesteigertes Risiko für Pfortaderthrombosen	1
Noncanonical Regulation of ACKR3/CXCR7 on Lipid Mediators in Immunothrombotic Platelet Response following FcγRIIa Stimulation	1
Post Partum Haemorrhage: prepartum plasmin and thrombin generation is similar in women with and without PPH	1
The evidence of enlarged platelets with reduced expression of glycoprotein Ib/IX might indicate recessive inherited thrombocytopenias other than Bernard-Soulier Syndrome	1
From Code to Clots: Applying Machine Learning to Clinical Aspects of Venous Thromboembolism Prevention, Diagnosis, and Management	1
Effectiveness of emicizumab under real-world conditions in patients of all ages with hemophilia A with and without FVIII inhibitors: Third interim analysis of the non-interventional study EMIIL	1
Clot-Wave-Analyse könnte individualisierte Therapie bei Hämophilie A verbessern	1
Promoting young talents - “Coagulation for bloody beginners” („Gerinnung für blutige Anfänger*innen“)	1
Antithrombotic Therapy in Cancer Patients with Cardiovascular Diseases: Daily Practice Recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) a	0
Expression and Release of Tumor Cell Tissue Factor Triggers Recurrent Thromboembolism in a Patient with Endometrial Cancer	0
Update on Cancer-Associated Venous Thromboembolism in Children	0
Type 2B von Willebrand Disease: Early Manifestation as Neonatal Thrombocytopenia	0
Diagnosis and Therapy of Visceral Vein Thrombosis: An Update Based on the Revised AWMF S2k Guideline	0
Tackling the implementation hurdle: User-centric validation of a machine-learning decision support tool for the screening of mild bleeding disorders	0
Health-related quality-of-life outcomes 4 years after treatment with valoctocogene roxaparvovec	0
	0
Anti-Thrombin IgA in a Patient with Multiple Myeloma Leading to In Vitro Interference in Multiple Coagulation Tests and Confounding Diagnosis	0

A Cross-sectional Analysis of Treatment in PUPs in 2021 in Germany – First Data from the GEPHARD Study Group	0
Thrombozyten: Blutstillung ohne Gerinnselbildung	0
Specific reversal of factor Xa inhibitors with single domain antibodies	0
Procoagulant Platelets as a Compensatory Mechanism and Their Impact on Bleeding Severity in Hemophilia A	0
Molecular Genetics of Fletcher and Fitzgerald Traits	0
Controlling Patient Multiple Electrode Aggregometry Results with Blood Samples of Blood Donors Improves Clinical Interpretation	0
Severe autoimmune Heparin Induced Thrombocytopenia with persistence over years: a case report	0
Impact of Tyrosine Kinase Inhibitors Applied for First-Line Chronic Myeloid Leukemia Treatment on Platelet Function in Whole Blood of Healthy Volunteers In Vitro	0
Sequential combinations of rapid immunoassays for prompt recognition of heparin-induced thrombocytopenia: a prospective validation study	0
In-vitro Evaluation of Anti-PEG Antibody Effects on the Activation of PEGylated Therapeutic FVIII and FIX Products	0
	0
	0
Non–Vitamin K Antagonist Oral Anticoagulants in Coronary Artery Disease	0
Novel Likely Pathogenic Variant in the A3 Domain of von Willebrand Factor Leading to a Collagen-Binding Defect	0
Von Willebrand Disease—Specific Aspects in Women	0
COVID-19: Cardio-pulmonary and Vascular Manifestations	0
Aspects of long-term joint health in haemophilia A: inSight Joint Health tool	0
The change in factor VIII therapy in Germany - a follow-up retrospective data analysis from smart medication ScanDoc over four years	0
Interventional Treatment Options in Children with Extracranial Vascular Malformations	0
Etranacogene dezaparvovec hemophilia B gene therapy phase 2b trial final results: stable and durable FIX level expression over 5 years [ENCORE]	0
Post–Pulmonary Embolism Syndrome: An Update Based on the Revised AWMF-S2k Guideline	0
GTH News	0
Update on the Use of Thrombopoietin-Receptor Agonists in Pediatrics	0
New Anticoagulants in Neonates, Children, and Adolescents	0
Extensive Thromboembolism in a Young Male with Asymptomatic COVID-19 Infection and Heterozygous Factor V Leiden Mutation	0
Direct Oral Anticoagulants for Pulmonary Embolism	0
Nachruf auf Rainer B. Zotz und Ankündigung der BDDH-Veranstaltung auf der GTH in Frankfurt 2023	0
Double CRISPR/Cas9-knockout of ER chaperones, ERGIC transporters and GABARAPs reveal additive and dominant effect on FVIII secretion	0
TFPI deletion in myeloid cells exacerbates atherosclerotic plaque development	0
Joint health and physical activity in people with haemophilia A without factor VIII inhibitors before switching to emicizumab prophylaxis: Beyond ABR study interim analysis	0
Disorders of Thrombosis and Hemostasis in Cancer	0
Detection of joint bleeding symptoms in Haemophilia with the Noraxon system – pilot study	0
Natural history of isolated distal deep vein thrombosis without anticoagulation. Prospective cohort under ultrasound surveillance	0
	0
Perioperative Management for Port Catheter Procedures in Pediatric Patients with Severe Hemophilia and Inhibitors	0
Perioperative Management with Efanesoctocog Alfa in Adults, Adolescents, and Children with Severe Hemophilia A in the Phase 3 XTEND Clinical Program	0
Venous thromboembolism therapy with edoxaban in daily - care patients: results from the DRESDEN NOAC REGISTRY	0
Pitfalls in Coagulation Testing	0
FXIa-Triggered Thrombin Generation to Predict Breakthrough Bleeding in Acquired Hemophilia A: Data from the GTH-AHA-EMI Study	0
When and How to Combine Antiplatelet and Anticoagulant Drugs?	0
Epithelial thrombin-PAR1 signaling and Nippostrongylus brasiliensis infection drive small intestinal villus vascularization	0
Sustained Efficacy of Marstacimab in Adults and Adolescents with Severe Hemophilia A or B without Inhibitors	0
Thrombotic Ghost as a Complication of Anticoagulation Therapy: The Challenge of Anticoagulating Intracardiac Thrombi in Patients with Factor VII Deficiency	0
Priv.-Doz. Dr. med. Rainer B. Zotz	0
Comparing thrombin generation in hemophilia A and patients with non-valvular atrial fibrillation on oral anticoagulation	0
Challenging Situations in the Treatment of Cancer-Associated Thrombosis	0
Hemostaseology in Pediatrics	0
Antithrombotic Treatment for Left Ventricular Assist Devices: One Does Not Fit All	0
Development of an innovative approach based on targeted anticoagulation for the treatment of VTE	0
Probleme der Digitalisierung sowie Protest gegen das Finanzstabilisierungsgesetz	0
Evidence-Based Medicine: Principles and Values as Illustrated by the Case of Patient Blood Management	0
Natural IgM antibodies reduce the prothrombotic potential of post-translationally modified collagen	0
Combining Diagnostics and Research in an Academic Laboratory	0
Mim8 Prophylaxis Beyond Bleeding: Investigating Multifaceted, Patient-reported Outcomes for Hemophilia A in the FRONTIER2 Study	0
Efficacy and safety of Mim8 prophylaxis in adults and adolescents with hemophilia A with or without inhibitors: Phase 3, open-label, randomized, controlled FRONTIER2 study	0
Global Coagulation Testing in Acute Care Medicine: Back to Bedside?	0
Utility of Global Hemostatic Assays in Patients with Bleeding Disorders of Unknown Cause	0
Pulmonary Hypertension and COVID-19	0
Platelets and Sera from Donors of Convalescent Plasma after Mild COVID-19 Show No Procoagulant Phenotype	0
Thrombozytopenie: Sind Thrombozytentransfusionen vor Legen eines ZVK verzichtbar?	0
	0
Analysis of the platelet activation profile in a novel experimental mouse model of AAA formation and progression	0
Cancer-Associated Venous Thromboembolism—Diagnostic and Therapeutic Considerations: An Update Based on the Revised AWMF S2k Guideline	0
Hemostasis modification in the presence of concizumab combined with donors' platelets, rFVIIa and/or tranexamic acid assessed by modified rotational thromboelastometry in patients with Glanzm	0
Applicability of and adherence to anticoagulation-related standard-operating-procedures in standard surgical procedures – a single center quality control experience	0
The Impact of Genetic and Acquired Risk Factors on Thromboembolic Events: A Retrospective Study	0
Efficacy and safety of valoctocogene roxaparvovec 4 years after gene transfer in GENEr8-1	0
Grundlagen zur Anwendung von Andexanet	0
VITT-like anti-PF4 antibodies need to be considered in patients with thrombocytopenia and thrombosis	0
	0
A Novel Fibrinogen Mutation p.BβAla68Asp Causes an Inherited Dysfibrinogenemia	0
A Novel Rapid Clotting Assay for Tissue Factor Pathway inhibitor (TFPI)	0
Platelet desialylation is mediated by upregulated plasmatic neuraminidase activity and linked to platelet dysfunction in sepsis	0
GPVI-mediated platelet activation aggravates inflammation and progressive aortic wall remodelling in abdominal aortic aneurysm formation	0
The Use of DOACs in Pediatrics: Current Therapeutic and Prophylactic Indications, Cardiac Indications, and Real-World Evidence—A Review	0
A reinforced fibrin- and platelet-rich layer on the exterior surface of hemostatic blood clots in vivo is formed by platelet contraction	0
Clinical laboratories need more information about commercially available reagents to prepare to IVDR: A call from ICSH	0
Thiol isomerase inhibition with bacitracin or rutin interferes with tissue factor production in myelomonocytic HL-60 cells and isolated AML blasts	0
Die Gesellschaft für Thrombose- und Hämostaseforschung e.V. informiert	0
Increasing Use of Anticoagulants in Germany and Its Impact on Hospitalization for Tooth Extraction	0
Im letzten Augenblick verhindert: Geplante Übertragung der Richtlinienbefugnis bezüglich Herstellung und Anwendung von Blut und Blutprodukten von der Bundesärztekammer (BÄK) auf das Paul-Ehrlich-Insti	0
Erratum: Effect of DDAVP on Platelet Activation and Platelet-Derived Microparticle Generation	0
Management of Recurrent Venous Thromboembolism in Severe Immune Thrombocytopenia: A Case Report and a Review of the Literature	0
	0
Fachgespräche zur Plasma-Versorgung in Deutschland und Sachstand zur neuen Gebührenordnung für Ärzte (GOÄ)	0
Plasma factors might interfere with platelet function in patients with decompensated liver cirrhosis	0
Schwere nächtliche Hypoxie erhöht Wahrscheinlichkeit einer unprovozierten venösen Thromboembolie	0
Anticoagulation Therapy in Cancer Patients with Thrombosis in the Outpatient Sector of Germany (The CERTIFICAT Initiative)—German Practice of Anticoagulation Therapy of Cancer Patients with Thrombosis	0
Comparison of Performances among Four Bleeding-Prediction Scores in Elderly Cancer Patients with Venous Thromboembolism	0
Paving the way to assay automation: Improving and simplifying VWF activity determination of VWF concentrates	0
Assessment of plasma levels of D-dimer and prothrombin fragment 1+2 in patients on direct oral anticoagulants versus vitamin K antagonists	0
100 Years of Thrombotic Thrombocytopenic Purpura: A Story of Death and Life	0
VTE Risk Assessment and Prevention in Pregnancy	0
Flow Chamber Analyses in Cardiovascular Research: Impact of Platelets and the Intercellular Crosstalk with Endothelial Cells, Leukocytes, and Red Blood Cells	0
Pulmonary Embolism: Don't Start Me to Talkin'	0